Filing Flows › Comparisons › ROIV vs ELAB
Roivant Sciences vs Pmgc Holdings: ROIV and ELAB compared
Roivant Sciences is the larger company: $1.4M of revenue in its latest quarter (Q1 FY27) against $1.3M for Pmgc Holdings (Q2 2026).
Where the money goes: ROIV and ELAB
Roivant Sciences (ROIV) · Q1 FY27
Roivant Sciences, Q1 FY27: revenue $1.4M (-34% year over year), net loss $291M, operating cash flow −$271M. The chart follows the revenue to costs, profit and cash.
Pmgc Holdings (ELAB) · Q2 2026
Pmgc Holdings, Q2 2026: revenue $1.3M, operating margin -225.1%, net loss $2.9M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Roivant Sciences (ROIV) | Pmgc Holdings (ELAB) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q2 2026 |
| Revenue | $1.4M | $1.3M |
| Revenue growth, Y/Y | -34% | — |
| Operating margin | n/m | -225.1% |
| Net earnings | −$291M | −$2.9M |
| Net margin | — | -225.1% |
| Operating cash flow | −$271M | −$2.0M |
Questions
Which is bigger, Roivant Sciences or Pmgc Holdings?
Roivant Sciences is the larger company: $1.4M of revenue in its latest quarter (Q1 FY27) against $1.3M for Pmgc Holdings (Q2 2026).
More: Roivant Sciences earnings · how Roivant Sciences makes money · Pmgc Holdings earnings · how Pmgc Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.